58804-10-7 Usage
Description
3,6-Dichloropyridine-2-methanol is a chemical compound with the molecular formula C6H5Cl2NO. It is a derivative of pyridine and is composed of a pyridine ring with two chlorine atoms and a hydroxyl group attached. It is a white to off-white crystalline solid with a melting point of 159-163°C and a boiling point of 227-229 °C at 760 mmHg.
Uses
Used in Organic Synthesis:
3,6-Dichloropyridine-2-methanol is used as a building block in organic synthesis for the creation of various chemical compounds.
Used in Pharmaceutical Research:
It is utilized as an intermediate in pharmaceutical research for the development of new drugs.
Used in Agrochemical Production:
3,6-Dichloropyridine-2-methanol is used as an intermediate in the production of agrochemicals, contributing to the development of pesticides and other agricultural chemicals.
Used in Specialty Chemicals Production:
It is also employed as an intermediate in the production of specialty chemicals for various applications.
Safety Precautions:
3,6-Dichloropyridine-2-methanol is considered to be a hazardous chemical, and proper precautions should be taken when handling and storing it to ensure safety.
Check Digit Verification of cas no
The CAS Registry Mumber 58804-10-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,8,0 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 58804-10:
(7*5)+(6*8)+(5*8)+(4*0)+(3*4)+(2*1)+(1*0)=137
137 % 10 = 7
So 58804-10-7 is a valid CAS Registry Number.
58804-10-7Relevant articles and documents
FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
-
Page/Page column 51, (2011/02/18)
The present invention relates to compounds that are sodium channel inhibitors and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula I: wherein W1, W2, W3, R1, Q, X1, X2 and X3 are as described herein, to methods for the preparation and use of the compounds and to pharmaceutical compositions containing the same.
